Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 912 of 6351
-
Own muscle cells injected into sphincter may curb fecal incontinence
Disease control Recruiting nowThe objective of this study is the final assessment of clinical safety and efficacy of autologous autologous skeletal muscle derived cells for patients with urge fecal incontinence due to external anal sphincter dysfunction caused by its disruption and/or weakness.
Phase 3 • Sponsor: Innovacell GmbH • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a VR headset turn nursing students into Bleeding-Control experts?
Knowledge-focused CompletedThe goal of this clinical trial is to learn if a 360-degree interactive virtual reality (VR) video simulation works to improve first aid knowledge, knowledge retention, and self-efficacy in stopping severe bleeding among first-year undergraduate nursing students. The main questio…
Sponsor: Manisa Celal Bayar University • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Brain radiation shield: Alzheimer's drug tested in kids with cancer
Symptom relief OngoingThis phase III trial compares memantine to placebo in treating patients with primary central nervous system tumors. Memantine may block receptors (parts of nerve cells) in the brain known to contribute to a decline in cognitive function. Giving memantine may make a difference in …
Phase 3 • Sponsor: Children's Oncology Group • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Laser zaps recurrent brain tumors: new trial tests minimally invasive option
Disease control Recruiting nowRandomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Sponsor: Monteris Medical • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy targets hard-to-treat mesothelioma
Disease control Recruiting nowPilot study of the feasibility of an innovative multimodal treatment combining intrapleural photodynamic therapy with videothoracoscopy followed by adjuvant immunotherapy with anti-PD-1 Nivolumab antibodies in patients with malignant pleural mesothelioma
Phase 2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New radiation combo shows promise for tough lung cancers
Disease control CompletedThe combination of immune checkpoint inhibitors (ICI) and local ablative radiotherapy has been demonstrated to be able to increase the survival of patients with metastatic driven-genes negative non-small cell lung cancer. Various dose-fraction of radiotherapy could exert differen…
Phase 2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Radioactive water scan could spot hidden heart disease
Diagnosis OngoingThis a Phase 3, prospective, open-label, multicenter study of \[15-O\]-H2O injection for PET imaging of subjects with suspected CAD. Approximately 182 evaluable participants with suspected CAD referred for testing will be included in the study at approximately 10 study sites in t…
Phase 3 • Sponsor: MedTrace Pharma A/S • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Can magnetic pulses rewire the brain to ease movement symptoms?
Symptom relief OngoingBackground: Functional movement disorders (FMD) involve involuntary movements that are not due to a recognized neurological or medical cause. FMD can cause major disability. Researchers want to learn more to create better treatments for FMD. Objective: To test whether non-inva…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a single dose of radiation during surgery improve pancreatic cancer outcomes?
Disease control OngoingThis study is designed to investigate the safety of intraoperative radiation therapy (IORT) in patients with localized pancreatic cancer undergoing surgical resection after neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT).
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could chemo after surgery keep pancreatic cancer at bay?
Disease control Recruiting nowThis phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroendocrine tumors. Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of …
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Triple drug cocktail shows promise for untreated liver cancer
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of triplet therapy of nivolumab, relatlimab and bevacizumab versus nivolumab and bevacizumab in participants with untreated advanced/metastatic hepatocellular carcinoma (HCC).
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Liver cancer remission: is surgery still needed?
Disease control CompletedHepatocellular carcinoma (HCC) accounts for more than 90% of primary liver cancers and is the sixth most common cancer in the world and ranked third in mortality. Most patients with HCC are diagnosed at an advanced stage and miss the opportunity for radical surgical resection, th…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental cell therapy targets Hard-to-Treat myeloma
Disease control OngoingPhase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in subjects with relapsed / refractory Multiple Myeloma (RRMM).
Phase 1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New weekly shot shows promise for rare low blood sugar disorder
Disease control OngoingThis study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15136 when used as add-on therapy in subjects with CHI with persistent hypoglycemia while on standard of care treatment (SoC). HM15136 will be administered once weekly in multipl…
Phase 2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a hidden patient reveal why cheap diarrhea treatment is underused?
Knowledge-focused CompletedDiarrhea is the second leading cause of death for children around the world, although nearly all of these deaths could be prevented with an inexpensive and simple treatment: oral rehydration salts (ORS). Many children with diarrhea do not receive ORS when they seek treatment and …
Sponsor: RAND • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can tape and a shot ease Post-Stroke shoulder pain?
Symptom relief CompletedThe aims of this study is to investigate sono-guided shoulder steroid injection combined with Kinesiotaping applications in reducing shoulder pain, improving functional performance on upper extremity and quality of life in stroke patients with hemiplegic shoulder pain.
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New drug aims to stop extra bone formation in rare disease
Disease control Recruiting nowThis Phase 2, Randomized, Double-Blind, Placebo-Controlled Study is intended to evaluate the Efficacy, Safety, and Tolerability and PK of INCB000928 administered to participants with a clinical diagnosis of fibrodysplasia ossificans progressiva (FOP).
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Spit test could spot ovarian cancer earlier
Diagnosis OngoingOVAmiARN is a multicentre, prospective, longitudinal, non-interventional, observational study carried out in 8 obstetrics and gynecology departments in France; in order to describe the evolution of salivary miRNA expression between the pre-operative and post-therapy visits accord…
Sponsor: ZIWIG • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Two-Antibody combo takes on advanced cancers
Disease control OngoingPhase Ib/II open label, multicenter study to evaluate the efficacy and safety of AK112 (anti-PD-1 and VEGF bispecific antibody) combined with AK117#AntiCD47 Antibody# in advanced malignant tumors
Phase 1/2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a shot stop asthma attacks in city kids?
Disease control OngoingThis is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerbations in urban children and adolescents with T2-high exacerbation-prone asthma.
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC